Press & News

People are different and so is their cancer, patients should be treated individually.

New Independent market survey shows great demand for 2cureX product portfolio

Latest News

2cureX presents its Q3 report

Latest press and news

Nov 24

IR

Regulatory

Report

2cureX publishes interim report for the third quarter and first nine months of 2022

Nov 22

IR

Invitation to 2cureX webcast and conference call on November 24, 2022

Nov 14

IR

Regulatory

2cureX discloses status of 2022 plans, goals for 2023 and its estimates of potential market development in the coming years

Nov 1

IR

Invitation to 2cureX Strategy Deep-Dive

Oct 11

IR

Independent market survey shows great demand for 2cureX product portfolio

Oct 6

IR

Co-inventor of 2cureX patents awarded Nobel Prize in Chemistry

Sep 29

IR

Regulatory

2cureX terminates liquidity provision service

Sep 19

IR

Change of distribution partner in Portugal